FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

VEDANTA PARTNERS, LLC		 2. Issuer Name and Ticker or Trading Symbol

REVIVA PHARMACEUTICALS HOLDINGS, INC. [ RVPH ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O VEDANTA MANAGEMENT LP, 250 WEST 55TH STREET, SUITE 13D		 3. Date of Earliest Transaction (MM/DD/YYYY)

9/8/2022
(Street)

NEW YORK, NY 10019
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Pre-Funded Warrant $0.0001 9/8/2022  P   869565     (1) (1)Common Stock 869565 $2.5299 869565 I See Footnote (2)
Pre-Funded Warrant $0.0001 9/8/2022  P   513834     (1) (1)Common Stock 513834 $2.5299 513834 I See Footnote (3)
Common Stock Warrant (right to buy) $2.40 9/8/2022  P   869565     (4)9/8/2027 Common Stock 869565 $0.0001 869565 I See Footnote (2)
Common Stock Warrant (right to buy) $2.40 9/8/2022  P   513834     (4)9/8/2027 Common Stock 513834 $0.0001 513834 I See Footnote (3)
Explanation of Responses:
(1) The pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer.
(2) Held directly by Beta Operators Fund, L.P. ("Beta Operators Fund"). Vedanta Associates, L.P. ("Vedanta Associates") is the general partner of Beta Operators Fund. Vedanta Partners, LLC ("Vedanta Partners") is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Associates, Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein.
(3) Held directly by Vedanta Associates-R, L.P. ("Vedanta Associates-R"). Vedanta Partners is the general partner of Vedanta Associates-R, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein.
(4) The common stock warrants expire on September 8, 2027 and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
VEDANTA PARTNERS, LLC
C/O VEDANTA MANAGEMENT LP
250 WEST 55TH STREET, SUITE 13D
NEW YORK, NY 10019
X

Vedanta Associates-R, LP
C/O VEDANTA MANAGEMENT LP
250 WEST 55TH STREET, SUITE 13D
NEW YORK, NY 10019
X

VEDANTA ASSOCIATES, L.P.
C/O VEDANTA MANAGEMENT LP
250 WEST 55TH STREET, SUITE 13D
NEW YORK, NY 10019
X

BETA OPERATORS FUND, L.P.
C/O VEDANTA MANAGEMENT LP
250 WEST 55TH STREET, SUITE 13D
NEW YORK, NY 10019
X

SAXENA PARAG
250 WEST 55TH STREET, SUITE 13D
NEW YORK, NY 10019
X
Signatures
/s/ Parag Saxena - for Vedanta Partners, LLC, by Parag Saxena, its CEO9/12/2022
**Signature of Reporting PersonDate

/s/ Parag Saxena - for Vedanta Associates-R, LP, by Vedanta Partners, LLC, its general partner, by Parag Saxena, its CEO9/12/2022
**Signature of Reporting PersonDate

/s/ Parag Saxena - for Vedanta Associates, LP, by Vedanta Partners, LLC, its general partner, by Parag Saxena, its CEO9/12/2022
**Signature of Reporting PersonDate

/s/ Parag Saxena - for Beta Operators Fund, L.P., by Vedanta Associates, LP, its general partner, by Vedanta Partners, LLC, its general partner, by Parag Saxena, its CEO9/12/2022
**Signature of Reporting PersonDate

/s/ Parag Saxena9/12/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Tenzing Acquisition (NASDAQ:TZAC)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Tenzing Acquisition Charts.
Tenzing Acquisition (NASDAQ:TZAC)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Tenzing Acquisition Charts.